Funding

All costs associated with the development of this study were supported by eVisit Ltd., Hungary, and PharmIn s.r.o., Slovakia, and funded by UCB Pharma, which also funded the Rapid Service Fee.

Medical Writing, Editorial, and Other Assistance

Medical writing support was provided by Sreeharsha, MPharm, and Ritu Guglani, MD, Enago Life Sciences, India, and funded by UCB Pharma. Publication management was provided by Costello Medical, UK, and funded by UCB Pharma.

Authorship

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Author Contributions

All authors contributed to the study conception and design. Material preparations were performed Želmíra Macejová, Spyridon Gkalpakiotis, and Leona Procházková. Data collection and analysis were performed by Zoltán Tóth and Pavel Prágr. The first draft of the manuscript was written by Marta Olejárová and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Prior Presentation

Previously presented as interim data at Hungarian MRE Congress 2021, 23–26 Sep, Debrecen, Hungary.

Disclosures

Marta Olejárová is a consultant, speaker, or investigator for AbbVie, Eli Lilly, Novartis, Sandoz, Pfizer, Amgen, Viatris, Bausch Health). Želmíra Macejová has been a speaker or investigator for AbbVie, Biogen, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. Spyridon Gkalpakiotis has served as a consultant, speaker, or investigator for AbbVie, Celgene, Eli Lilly, Janssen, Leo Pharma, Novartis, Pfizer, and UCB. Leona Procházková has served as a consultant, speaker, or investigator for AbbVie, Biogen, Celgene, Eli Lilly, Gilead, Glaxo Smith Kline, Janssen, Novartis, Pfizer, and UCB.

No potential conflict of interest was reported by Zoltán Tóth. Pavel Prágr has worked as an external medical consultant for pharmaceutical companies in the Czech and Slovak Republics.

Compliance with Ethics Guidelines

This was a descriptive, voluntary, non-interventional questionnaire. The physicians were informed about the questionnaire prior to participating; participation was voluntary and data collected were anonymized before analysis. Consent was implied on the return of a completed questionnaire. The agreement template contains a confidentiality clause as well as a specific mention of the voluntariness to participate. This survey did not need IRB approval as per Hungarian Medical Research Council’s Scientific and Research Ethics Committee legislation, 23/2002. (V. 9.) Decree of the Minister of Health on medical research conducted on humans (Validity: 20.08.2019 -23/2002).

Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.